Edition:
United States

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

7.10USD
3:59pm EST
Change (% chg)

$-0.05 (-0.70%)
Prev Close
$7.15
Open
$7.22
Day's High
$7.22
Day's Low
$6.85
Volume
2,806
Avg. Vol
4,140
52-wk High
$7.50
52-wk Low
$5.05

Latest Key Developments (Source: Significant Developments)

Chembio Diagnostics Awarded UNICEF Contract
Tuesday, 28 Nov 2017 08:50am EST 

Nov 28 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS AWARDED UNICEF CONTRACT TO SUPPLY POINT-OF-CARE DPP® ZIKA ASSAYS AND DPP® MICRO READERS.CHEMBIO DIAGNOSTICS INC - ‍CO HAS BEEN AWARDED A CONDITIONAL LONG TERM ARRANGEMENT FROM UNICEF FOR PURCHASES OF COMPANY'S DPP ZIKA SYSTEM​.CHEMBIO DIAGNOSTICS - ‍UNICEF LTA, WHICH IS VALID THROUGH DEC 31, 2019, INCLUDES PURCHASE COMMITMENT OF $1.5 MILLION, POSSIBLE PURCHASES UP TO $3.4 MILLION.  Full Article

Chembio Diagnostics posts Q3 loss of $0.05 per share
Wednesday, 8 Nov 2017 04:15pm EST 

Nov 8 (Reuters) - Chembio Diagnostics Inc :Chembio diagnostics reports third quarter 2017 financial results.Q3 loss per share $0.05.Q3 revenue rose 102 percent to $7.6 million.  Full Article

Chembio Diagnostics says CFO Richard Larkin to retire by Dec 31
Thursday, 17 Aug 2017 05:01pm EDT 

Aug 17 (Reuters) - Chembio Diagnostics Inc -:Chembio Diagnostics Inc says Richard J. Larkin, CFO, has informed company of his intention to retire by December 31, 2017‍​ - sec filing.Chembio Diagnostics Inc - an external search for a new company CFO will commence immediately‍​.Chembio Diagnostics Inc - Larkin will continue his role with the company until the effective date of his retirement - sec filing.Chembio Diagnostics - Larkin's retirement is effective on earlier to occur of December 31, 2017 or the date on which new cfo has been engaged.  Full Article

Chembio Diagnostics reports Q2 loss per share of $0.18
Wednesday, 9 Aug 2017 04:15pm EDT 

Aug 9 (Reuters) - Chembio Diagnostics Inc :Chembio Diagnostics reports second quarter 2017 financial results.Q2 loss per share $0.18.Q2 revenue rose 26 percent to $4.11 million.  Full Article

Chembio's DPP Zika System including the DPP Micro Reader approved by Brazil's Health Regulatory Agency
Wednesday, 5 Jul 2017 08:50am EDT 

July 5 (Reuters) - Chembio Diagnostics Inc :Chembio's DPP® zika system including the DPP® micro reader approved by Brazil's Health Regulatory Agency.Chembio Diagnostics - Has received approval for commercial use in Brazil of DPP micro reader by ANVISA in collaboration with Bio-Manguinhos/Fiocruz.  Full Article

Chembio diagnostics announces At-The-Market-Program
Tuesday, 27 Jun 2017 04:30pm EDT 

June 27 (Reuters) - Chembio Diagnostics Inc ::Chembio Diagnostics announces at--market program.Chembio Diagnostics- announced that it has established an "at--market" program through which it may offer and sell up to $21.2 million of common stock.Cantor Fitzgerald & Co. will be acting as sales agent.  Full Article

Acuta Capital Partners reports a 10.3 pct passive stake in Chembio Diagnostics
Monday, 12 Jun 2017 06:17am EDT 

June 12 (Reuters) - Chembio Diagnostics Inc :Acuta Capital Partners LLC reports a 10.3 percent passive stake in Chembio Diagnostics Inc as of May 31, 2017 - SEC filing.  Full Article

Chembio Diagnostics reports Q1 loss per share $0.13
Tuesday, 9 May 2017 04:10pm EDT 

May 9 (Reuters) - Chembio Diagnostics Inc :Chembio Diagnostics reports first quarter 2017 financial results.Q1 loss per share $0.13.Q1 revenue fell 4.2 percent to $6.3 million.Chembio Diagnostics Inc - Had cash and cash equivalents of $5.6 million as of March 31, 2017, compared with $10.6 million as of December 31, 2016.  Full Article

Chembio Diagnostics Q4 loss per share $0.21
Tuesday, 7 Mar 2017 04:10pm EST 

Chembio Diagnostics Inc : Chembio diagnostics reports 2016 financial results . Q4 loss per share $0.21 .Q4 revenue fell 3.8 percent to $4.25 million.  Full Article

Chembio to acquire RVR diagnostics, establish operations in Southeast Asia
Friday, 4 Nov 2016 08:50am EDT 

Chembio Diagnostics Inc : Chembio agrees to acquire Malaysia-based RVR Diagnostics and establish operations in Southeast Asia .Chembio Diagnostics Inc - Chembio will pay up to $1.5 million in cash and up to $2 million in Chembio stock for the acquisition.  Full Article

BRIEF-Chembio receives $8.5 mln commitment from Bio-Manguinhos to purchase components for production of dpp Assays in Brazil during 2018

* CHEMBIO RECEIVES $8.5 MILLION COMMITMENT FROM BIO-MANGUINHOS TO PURCHASE COMPONENTS FOR PRODUCTION OF DPP® ASSAYS IN BRAZIL DURING 2018